References
- ASA. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists' Task Force on Blood Component therapy. Anesthesiology 1996; 84: 732–747
- Ekeroma A J, Ansari A, Stirrat G M. Blood transfusion in obstetrics and gynecology. British Journal of Obstetrics and Gynaecology 1997; 104: 278–284
- Goodnough L T. Risks of blood transfusion. Critical Care Medicine 2003; 31: S678–S686
- Khadra M, Rigby C, Warren P, Leighton N, Johanson R. A criterion audit of women's awareness of blood transfusion in pregnancy. BMC Pregnancy Childbirth 2002; 2: 7–9
- Marcucci C, Madjdpour C, Spahn D R. Allogenic blood transfusions, benefits, risks and clinical indications in countries with low or high human development index. British Medical Bulletin 2004; 70: 15–28
- McVay P A, Hoag R W, Hoag M S, Toy P T. Safety and use of autologous blood donation during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology 1989; 160: 1479–1486
- Segal J B, Blasco-Colmenares E, Norris E J, Guallar E. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 2004; 44: 632–644
- Spahn D R. Strategies for transfusion therapy. Best Practice and Research. Clinical Anaesthesiology 2004; 18: 661–673
- Spahn D R, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 2000; 93: 242–255
- Wagner S J. Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sanguinis 2004; 86: 157–163
- Waterstone M, Bewley S. Incidence and predictors of severe obstetric morbidity: a case control study. British Medical Journal 2001; 322: 1089–1093